Filing Details
- Accession Number:
- 0001867096-23-000151
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-21 16:20:16
- Reporting Period:
- 2023-11-20
- Accepted Time:
- 2023-11-21 16:20:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1867096 | Xeris Biopharma Holdings Inc. | XERS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1743658 | Dawn Halkuff | C/O Xeris Biopharma Holdings, Inc. 1375 West Fulton Street, Suite 1300 Chicago IL 60607 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-20 | 5,410 | $1.84 | 5,410 | No | 4 | P | Indirect | By; DAWN HALKUFF REVOCABLE TRUST U/A DTD 08/25/2017 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By; DAWN HALKUFF REVOCABLE TRUST U/A DTD 08/25/2017 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 57,500 | Direct |
Footnotes
- The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
